Article

Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4): clinical description and genetic localization to chromosome 16q22.1.

Department of Neurology, University of Utah Medical Center, Salt Lake City 84112, USA.
The American Journal of Human Genetics (Impact Factor: 10.99). 09/1996; 59(2):392-9.
Source: PubMed

ABSTRACT The hereditary ataxias represent a clinically and genetically heterogeneous group of neurodegenerative disorders. Various classification schemes based on clinical criteria are being replaced as molecular characterization of the ataxias proceeds; so far, seven distinct autosomal dominant hereditary ataxias have been genetically mapped in the human genome. We report linkage to chromosome 16q22.1 for one of these genes (SCA4) in a five-generation family with an autosomal dominant, late-onset spinocerebellar ataxia; the gene is tightly linked to the microsatellite marker D16S397 (LOD score = 5.93 at theta = .00). In addition, we present clinical and electrophysiological data regarding the distinct and previously unreported phenotype consisting of ataxia with the invariant presence of a prominent axonal sensory neuropathy.

0 Bookmarks
 · 
189 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background We describe the clinical characteristics of a Swedish family with autosomal dominant cerebellar ataxia, sensory and autonomic neuropathy, additional neurological features and unknown genetic cause. Methods Fourteen affected family members were identified. Their disorder was characterized by neurological examination, MRI, electroneurography, electromyography, MIBG-scintigraphy, and tilt-testing. Results The disorder presented as a balance and gait disturbance starting between 16 and 47 years of age. Cerebellar ataxia progressed slowly over the course of decades, and MRI showed mild to moderate cerebellar atrophy. Sensory axonal polyneuropathy was the most prominent additional feature and occurred in all patients examined. Autonomic neuropathy caused pronounced orthostatic dysregulation in at least four patients. Several affected members showed muscle wasting, and mild upper or lower motor neuron signs were documented. Patients had no nystagmus but slow or hypometric horizontal saccades and ocular motor apraxia. Cognition remained unimpaired, and there were no non-neurological disease manifestations. The disorder affected men and women in successive generations in a pattern compatible with autosomal dominant inheritance without evidence of anticipation. A second family where 7 members had very similar symptoms was identified and its origin traced back to the same village in southern Sweden as that of the first family’s ancestors. All relevant known genetic causes of cerebellar ataxia were excluded by a novel next-generation sequencing approach. Conclusion We present two probably related Swedish families with a characteristic and novel clinical syndrome of cerebellar ataxia and sensory polyneuropathy. The study serves as a basis for the mapping of the underlying genetic cause.
    Parkinsonism & Related Disorders 07/2014; 20(7). DOI:10.1016/j.parkreldis.2014.03.029 · 4.13 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To elucidate the neuropathology in cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS), a novel cerebellar ataxia comprised of the triad of cerebellar impairment, bilateral vestibular hypofunction, and a peripheral sensory deficit. Brain and spinal neuropathology in 2 patients with CANVAS, together with brain and otopathology in another patient with CANVAS, were examined postmortem. Spinal cord pathology demonstrated a marked dorsal root ganglionopathy with secondary tract degeneration. Cerebellar pathology showed loss of Purkinje cells, predominantly in the vermis. The likely underlying sensory pathology in CANVAS is loss of neurons from the dorsal root and V, VII, and VIII cranial nerve ganglia-in other words, it is a "neuronopathy" rather than a "neuropathy." Clinically, CANVAS is a differential diagnosis for both spinocerebellar ataxia type 3 (or Machado-Joseph disease) and Friedreich ataxia. In addition, there are 6 sets of sibling pairs, implying that CANVAS is likely to be a late-onset recessive or autosomal dominant with reduced penetrance disorder, and identification of the culprit gene is currently a target of investigation.
    Neurology 03/2014; 82(16). DOI:10.1212/WNL.0000000000000352 · 8.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Genetic research on inherited ataxias has transformed our understanding of these conditions. The availability of genetic testing has shown that a classification based solely on clinical and pathologic findings is not adequate, and molecular genetic analysis is now mandatory for diagnostic accuracy and prognostic purposes. The epidemiology of these disorders is also being rewritten under the light of molecular genetic analysis. In this review, we discuss some of the recent advances on the hereditary cerebellar degenerations without a known metabolic defect, focusing on genotype-phenotype correlations in the spinocerebellar ataxias (SCAs) and Friedreich’s ataxia (FRDA). Three main biochemical pathways seem to be involved in the pathogenesis of inherited ataxias: 1) expansion of (CAG)n repeats within genes coding for polyglutamine-containing proteins (SCAs); 2) impairment of mitochondrial function (FRDA); and 3) dysfunction of ion channels (episodic ataxias, EA1, EA2). It is likely that many neurodegenerative conditions will prove to share basic molecular mechanisms, and therefore, data provided by the investigation of a particular disease is likely to be relevant to our global understanding of spinocerebellar degenerations and other degenerative disorders of the nervous system. A better knowledge of the molecular and cellular routes leading to neurodegeneration will provide a key to the design of rational therapies.
    The Neuroscientist 12/2000; 6(6):465-474. DOI:10.1177/107385840000600609 · 7.62 Impact Factor

Full-text (2 Sources)

Download
12 Downloads
Available from
Nov 4, 2014